PHASEBIO PHARMACEUTICALS INC - COM (PHASQ)

CUSIP: 717224109

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COM
Total 13F shares
17,128,828
Share change
-1,192,818
Total reported value
$60,120,843
Put/Call ratio
0%
Price per share
$3.51
Number of holders
49
Value change
-$5,208,494
Number of buys
20
Number of sells
26

Quarterly Holders Quick Answers

What is CUSIP 717224109?
CUSIP 717224109 identifies PHASQ - PHASEBIO PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) as of Q3 2020

As of 30 Sep 2020, PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,128,828 shares. The largest 10 holders included NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, Johnson & Johnson Innovation - JJDC, Inc., Rock Springs Capital Management LP, BlackRock Inc., VANGUARD GROUP INC, DAFNA Capital Management LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and STIFEL FINANCIAL CORP. This page lists 49 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.